Rebamipide Timing: After Meals
Rebamipide should be taken three times daily after meals based on the consistent dosing pattern observed in clinical trials and practice guidelines.
Evidence-Based Timing Recommendation
The research literature consistently demonstrates rebamipide administration after meals as the standard approach:
- In a 2025 randomized controlled trial examining rebamipide for dyspeptic symptom management, patients received 100 mg three times daily during the study period 1
- A 2003 surgical study specifically documented administration of 100 mg three times daily after meals for 7 days preoperatively, showing significant anti-inflammatory benefits 2
Rationale for Post-Meal Administration
Taking rebamipide after meals offers several practical advantages:
- Improved tolerability: Post-meal administration may reduce potential gastrointestinal side effects
- Consistent absorption: Food in the stomach provides a more stable environment for drug dissolution
- Better compliance: Linking medication to meals creates a reliable dosing schedule that patients can remember
Standard Dosing Protocol
The established regimen across multiple studies is:
- Dose: 100 mg per administration
- Frequency: Three times daily (TID)
- Timing: After breakfast, lunch, and dinner
- Duration: Varies by indication (typically 4-8 weeks for gastric protection)
Clinical Context
While rebamipide demonstrates efficacy in preventing NSAID-induced mucosal injury 3 and shows promise in various gastrointestinal conditions 4, the post-meal timing has remained consistent across diverse clinical applications. This timing pattern appears to be the standard of care based on the available clinical trial data, even though formal pharmacokinetic studies comparing pre-meal versus post-meal administration are not extensively documented in the provided evidence.
The post-meal timing should be maintained consistently throughout the treatment course to ensure optimal therapeutic benefit and patient adherence.